The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFevertree Regulatory News (FEVR)

Share Price Information for Fevertree (FEVR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,174.00
Bid: 1,179.00
Ask: 1,184.00
Change: 20.00 (1.73%)
Spread: 5.00 (0.424%)
Open: 1,134.00
High: 1,188.00
Low: 1,134.00
Prev. Close: 1,154.00
FEVR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

14 Dec 2023 14:33

RNS Number : 8819W
Fevertree Drinks PLC
14 December 2023

14th December 2023

Fevertree Drinks plc

("Fever-Tree" or the "Company")

Board Change

Fever-Tree, the world's leading supplier of premium carbonated mixers, is pleased to announce the appointment of David Lapp as a Non-Executive Director of the Company, effective from 1 January 2024.

David brings over 35 years of extensive industry expertise in the beverage sector including bottling, manufacturing, supply chain management and strategy across the North American and European markets. David served as Senior Vice President and Chief Supply Chain Officer for PepsiCo Beverages North America (PBNA) where he was accountable for leading the end-to-end supply chain operations for PBNA. Most recently he was Senior Vice President of Manufacturing Strategy across food and beverages for PepsiCo's North American business'. Prior to these roles, he served 22 years at Pepsi Bottling Group across the business' manufacturing and warehouse operations - culminating in the role of Global VP, Manufacturing and Warehouse Operations - before joining PepsiCo when it acquired the business in 2010.

As announced in May, Coline McConville will be stepping down from the Board of the Company on 31 December 2023, having served nine years as a Non-Executive Director.

As previously announced, Coline has been succeeded as Senior Independent Director by Kevin Havelock, who joined the Board in January 2018. Laura Hagan, who joined the Board and the Remuneration Committee in May 2021, has taken over from Coline as Chair of the Remuneration Committee.

Domenic De Lorenzo, Chair, said: "On behalf of the Board I would like to express a warm welcome to David. His extensive industry experience will play an important role in supporting Fever-Tree's continued successful expansion, particularly in North America, where the brand continues to go from strength to strength."

"I also want to thank Coline for her contributions to Fever-Tree as Non-Executive Director and latterly in her role as Senior Independent Director. She has played a significant role through an important period of growth for the Company and we wish her the very best."

ENDS

Regulatory Disclosures

The following information regarding the appointment of David Lapp, aged 58, is disclosed under Rule 17 and Schedule 2(g) of the AIM Rules for Companies:

Current directorships and/or partnerships:

The John Hay Estate at the Fells

Former directorships and/or partnerships (within the last five years):

The Pacific Northwest Bottling Group

Pepsi-Cola Advertising and Marketing Inc

David Lapp does not currently hold any shares in the Company.

There are no further disclosures to be made in accordance with Rule 17 and paragraph (g) of Schedule Two of the AIM Rules for Companies.

For further information:

Investor queries

Ann Hyams, Director of Investor Relations I ann.hyams@fever-tree.com I +44 (0)7435 828 138

Media queries

Oliver Winters, Director of Communications I oliver.winters@fever-tree.com I +44 (0)770 332 9024

Nominated Advisor and Broker - Investec Bank plc

David Flin I Alex Wright I +44 (0)20 7597 5970

Corporate Broker - Morgan Stanley & Co. International plc

Andrew Foster I Jessica Pauley I +44 (0)20 7425 8000

Financial PR advisers - FGS Global

Faeth Birch +44 (0)7768 943 171 I Anjali Unnikrishnan I +44 (0)7826 534 233

Notes to Editors:

Fever-Tree is the world's leading supplier of premium carbonated mixers for alcoholic spirits by retail sales value, with distribution to over 85 countries worldwide. Based in the UK, the brand was launched in 2005 to provide high quality mixers which could cater to the growing demand for premium spirits, in particular gin, but also increasingly for vodka, rum and whisky. The Company now sells a range of carbonated mixers to hotels, restaurants, bars and cafes ("On Trade") as well as selected retail outlets ("Off Trade").

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
BOAGPGPWPUPWGCC
Date   Source Headline
5th Dec 20177:00 amRNSNorth America Update
13th Nov 20171:37 pmRNSHolding(s) in Company
8th Nov 201711:19 amRNSHolding(s) in Company
7th Nov 20177:00 amRNSTrading Update
3rd Nov 201712:46 pmRNSBlock listing Interim Review
17th Aug 20179:24 amRNSHolding(s) in Company
31st Jul 20174:50 pmRNSHolding(s) in Company
26th Jul 20177:00 amRNSDirector/PDMR Shareholding
25th Jul 201712:03 pmRNSHolding(s) in Company
25th Jul 20177:00 amRNSInterim Results
25th May 20177:00 amRNSResult of Placing in Fevertree Drinks PLC
24th May 20174:35 pmRNSProposed placing of shares in Fevertree Drinks PLC
18th May 20177:00 amRNSGrant of Options
15th May 20175:05 pmRNSResult of AGM
15th May 20177:00 amRNSAGM Statement
25th Apr 201711:05 amRNSHolding(s) in Company
5th Apr 20177:00 amRNS2016 Annual Report and Notice of AGM
21st Mar 20177:00 amRNSPreliminary Results
27th Feb 20172:39 pmRNSHolding(s) in Company
17th Feb 201712:50 pmRNSHolding(s) in Company
30th Jan 201712:37 pmRNSHolding(s) in Company
27th Jan 20174:57 pmRNSHolding(s) in Company
24th Jan 20172:35 pmRNSHolding(s) in Company
24th Jan 20177:00 amRNSTrading Update
15th Nov 20169:31 amRNSHolding(s) in Company
11th Nov 20162:13 pmRNSHolding(s) in Company
7th Nov 20163:58 pmRNSHolding(s) in Company
7th Nov 20167:00 amRNSTrading Statement
26th Oct 20163:35 pmRNSHolding(s) in Company
20th Oct 20165:46 pmRNSHolding(s) in Company
30th Aug 20162:32 pmRNSHolding(s) in Company
26th Aug 20168:21 amRNSHolding(s) in Company
24th Aug 20169:42 amRNSHolding(s) in Company
23rd Aug 20164:59 pmRNSHolding(s) in Company
23rd Aug 20161:35 pmRNSHolding(s) in Company
19th Aug 20162:34 pmRNSHolding(s) in Company
18th Aug 20168:33 amRNSHolding(s) in Company
17th Aug 20169:56 amRNSHolding(s) in Company
5th Aug 201610:02 amRNSHolding(s) in Company
29th Jul 20163:49 pmRNSHolding(s) in Company
26th Jul 20167:00 amRNSInterim Results
8th Jun 20165:05 pmRNSHolding(s) in Company
6th Jun 20165:17 pmRNSHolding(s) in Company
26th May 20167:00 amRNSGrant of Options
19th May 20167:00 amRNSTrading Update
21st Apr 20165:48 pmRNSResult of AGM
24th Mar 20167:00 amRNSDirector/PDMR Shareholding
22nd Mar 201610:00 amRNS2015 Annual Report and Notice of AGM
14th Mar 20167:00 amRNSPreliminary Results
29th Feb 20165:30 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.